Literature DB >> 11576226

Neutralization of interferon-gamma in neonatal SOCS1-/- mice prevents fatty degeneration of the liver but not subsequent fatal inflammatory disease.

D V Bullen1, R Darwiche, D Metcalf, E Handman, W S Alexander.   

Abstract

Mice lacking the suppressor of cytokine signalling-1 (SOCS1) die within weeks of birth with extensive fatty degeneration of the liver, consistent with acute hepatic toxicity to interferon-gamma (IFN-gamma), and inflammation of multiple organs. We show here that treatment for 1 week from birth with neutralizing antibody to IFN-gamma rescues SOCS1-/- mice from lethal liver disease but the mice subsequently succumb to chronic inflammatory lesions characterized by T-lymphocyte infiltration of skeletal muscle, pancreas, lung, liver and skin. Elevated blood levels of eosinophils, neutrophils and platelets were also observed and the thymic lymphocyte population was depleted of CD4+ CD8+ T cells and showed a reduced CD4 : CD8 ratio. All T-cell populations in thymus, spleen and lymph node exhibited an increased proportion of cells bearing the activation marker CD44. These data suggest an important role for SOCS1 in T-lymphocyte regulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11576226      PMCID: PMC1783280          DOI: 10.1046/j.1365-2567.2001.01294.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  10 in total

1.  Lethality of interferon preparations for newborn mice.

Authors:  I Gresser; M G Tovey; C Maury; I Chouroulinkov
Journal:  Nature       Date:  1975-11-06       Impact factor: 49.962

2.  The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation.

Authors:  J G Zhang; A Farley; S E Nicholson; T A Willson; L M Zugaro; R J Simpson; R L Moritz; D Cary; R Richardson; G Hausmann; B T Kile; B J Kile; S B Kent; W S Alexander; D Metcalf; D J Hilton; N A Nicola; M Baca
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

3.  SOCS-1/JAB/SSI-1 can bind to and suppress Tec protein-tyrosine kinase.

Authors:  K i Ohya; S Kajigaya; Y Yamashita; A Miyazato; K Hatake; Y Miura; U Ikeda; K Shimada; K Ozawa; H Mano
Journal:  J Biol Chem       Date:  1997-10-24       Impact factor: 5.157

4.  Structure and function of a new STAT-induced STAT inhibitor.

Authors:  T Naka; M Narazaki; M Hirata; T Matsumoto; S Minamoto; A Aono; N Nishimoto; T Kajita; T Taga; K Yoshizaki; S Akira; T Kishimoto
Journal:  Nature       Date:  1997-06-26       Impact factor: 49.962

5.  A new protein containing an SH2 domain that inhibits JAK kinases.

Authors:  T A Endo; M Masuhara; M Yokouchi; R Suzuki; H Sakamoto; K Mitsui; A Matsumoto; S Tanimura; M Ohtsubo; H Misawa; T Miyazaki; N Leonor; T Taniguchi; T Fujita; Y Kanakura; S Komiya; A Yoshimura
Journal:  Nature       Date:  1997-06-26       Impact factor: 49.962

6.  Progressive glomerulonephritis in mice treated with interferon preparations at birth.

Authors:  I Gresser; C Maury; M Tovey; L Morel-Maroger; F Pontillon
Journal:  Nature       Date:  1976-09-30       Impact factor: 49.962

7.  A family of cytokine-inducible inhibitors of signalling.

Authors:  R Starr; T A Willson; E M Viney; L J Murray; J R Rayner; B J Jenkins; T J Gonda; W S Alexander; D Metcalf; N A Nicola; D J Hilton
Journal:  Nature       Date:  1997-06-26       Impact factor: 49.962

8.  The development of fatal myocarditis and polymyositis in mice heterozygous for IFN-gamma and lacking the SOCS-1 gene.

Authors:  D Metcalf; L Di Rago; S Mifsud; L Hartley; W S Alexander
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

9.  SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine.

Authors:  W S Alexander; R Starr; J E Fenner; C L Scott; E Handman; N S Sprigg; J E Corbin; A L Cornish; R Darwiche; C M Owczarek; T W Kay; N A Nicola; P J Hertzog; D Metcalf; D J Hilton
Journal:  Cell       Date:  1999-09-03       Impact factor: 41.582

10.  Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1.

Authors:  R Starr; D Metcalf; A G Elefanty; M Brysha; T A Willson; N A Nicola; D J Hilton; W S Alexander
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

  10 in total
  14 in total

Review 1.  Negative regulation of cytokine signaling.

Authors:  Akihiko Yoshimura
Journal:  Clin Rev Allergy Immunol       Date:  2005-06       Impact factor: 8.667

Review 2.  The molecular details of cytokine signaling via the JAK/STAT pathway.

Authors:  Rhiannon Morris; Nadia J Kershaw; Jeffrey J Babon
Journal:  Protein Sci       Date:  2018-12       Impact factor: 6.725

3.  Adenovirus-mediated transfer of the SOCS-1 gene to mouse lung confers protection against hyperoxic acute lung injury.

Authors:  Lakshmi Galam; Prasanna Tamarapu Parthasarathy; Young Cho; Seong Ho Cho; Yong Chul Lee; Richard F Lockey; Narasaiah Kolliputi
Journal:  Free Radic Biol Med       Date:  2015-04-04       Impact factor: 7.376

4.  STAT1β is not dominant negative and is capable of contributing to gamma interferon-dependent innate immunity.

Authors:  Christian Semper; Nicole R Leitner; Caroline Lassnig; Matthias Parrini; Tanel Mahlakõiv; Michael Rammerstorfer; Karin Lorenz; Doris Rigler; Simone Müller; Thomas Kolbe; Claus Vogl; Thomas Rülicke; Peter Staeheli; Thomas Decker; Mathias Müller; Birgit Strobl
Journal:  Mol Cell Biol       Date:  2014-04-07       Impact factor: 4.272

5.  Expression of SOCS-1 in the liver tissues of chronic hepatitis B and its clinical significance.

Authors:  Zhi-Xin Zhao; Qing-Xian Cai; Xiao-Mou Peng; Yu-Tian Chong; Zhi-Liang Gao
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

6.  Intracellular delivery of a cell-penetrating SOCS1 that targets IFN-gamma signaling.

Authors:  Antonio DiGiandomenico; Lukasz S Wylezinski; Jacek Hawiger
Journal:  Sci Signal       Date:  2009-07-21       Impact factor: 8.192

Review 7.  The molecular regulation of Janus kinase (JAK) activation.

Authors:  Jeffrey J Babon; Isabelle S Lucet; James M Murphy; Nicos A Nicola; Leila N Varghese
Journal:  Biochem J       Date:  2014-08-15       Impact factor: 3.857

8.  Glutathione-enhancing agents protect against steatohepatitis in a dietary model.

Authors:  Helieh S Oz; Hee-Jeong Im; Theresa S Chen; Willem J S de Villiers; Craig J McClain
Journal:  J Biochem Mol Toxicol       Date:  2006       Impact factor: 3.642

9.  Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation.

Authors:  Sarah E Hardison; Gina Herrera; Mattie L Young; Camaron R Hole; Karen L Wozniak; Floyd L Wormley
Journal:  J Immunol       Date:  2012-09-14       Impact factor: 5.422

10.  The lethal effects of transplantation of Socs1-/- bone marrow cells into irradiated adult syngeneic recipients.

Authors:  Donald Metcalf; Sandra Mifsud; Ladina Di Rago; Warren S Alexander
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-23       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.